Results 91 to 100 of about 124,514 (155)

Microbiome Therapeutic Lactiplantibacillus plantarum PMC105 for Systemic Carbapenem-Resistant Enterobacteriaceae Infections: Oral and Inhalation Efficacy In Vivo. [PDF]

J Microbiol Biotechnol
Sarafraz F, Seo H, Tajdozian H, Atashi A, Yoon Y, Kim S, Song HY.   +6 more
europepmc   +1 more source

Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

Int J Mol Sci
Bucataru A, Turcu-Stiolica A, Calina D, Balasoiu AT, Zlatian OM, Osman A, Balasoiu M, Ghenea AE.   +7 more
europepmc   +1 more source

Ceftazidime-avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. [PDF]

Infection
Chen J, Hu Q, Zhou P, Deng S.
europepmc   +1 more source

Community Origins and Regional Differences Highlight Risk of Plasmid-mediated Fluoroquinolone Resistant Enterobacteriaceae Infections in Children. [PDF]

Pediatr Infect Dis J, 2019
Logan LK, Medernach RL, Rispens JR, Marshall SH, Hujer AM, Domitrovic TN, Rudin SD, Zheng X, Qureshi NK, Konda S, Hayden MK, Weinstein RA, Bonomo RA.   +12 more
europepmc   +1 more source

High drug-pathogen mismatch in the management of invasive carbapenem-resistant Enterobacteriaceae infections at a tertiary hospital in Nigeria. [PDF]

IJID Reg
Adekanmbi O, Popoola O, Fowotade A, Idowu O, Ogunbosi B, Lakoh S, Adebiyi I.   +6 more
europepmc   +1 more source

Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data. [PDF]

Open Forum Infect Dis, 2019
Clancy CJ, Potoski BA, Buehrle D, Nguyen MH.   +3 more
europepmc   +1 more source

The Clinical and Molecular Epidemiology of CTX-M-9 Group Producing Enterobacteriaceae Infections in Children. [PDF]

Infect Dis Ther, 2019
Logan LK, Medernach RL, Domitrovic TN, Rispens JR, Hujer AM, Qureshi NK, Marshall SH, Nguyen DC, Rudin SD, Zheng X, Konda S, Weinstein RA, Bonomo RA.   +12 more
europepmc   +1 more source

Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae [PDF]

The Lancet Infectious Diseases, 2017
Bernd, Salzberger, Gerd, Fätkenheuer
openaire   +2 more sources

Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

Antimicrob Agents Chemother, 2020
Ackley R, Roshdy D, Meredith J, Minor S, Anderson WE, Capraro GA, Polk C.   +6 more
europepmc   +1 more source